Lanreotide vs octreotide LAR for patients with advanced gastroenteropancreatic neuroendocrine tumors: An observational time and motion analysis.

P RyanA McBrideD RayS PulgarR A RamirezE ElquzaJ P FavaroGeorge Dranitsaris

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2019)

clinicaltrials.gov Identifier: NCT03017690.

Keyphrases